CRF Connect Logo

Structural

Aortic Valve Intervention Learning Series

TAVR Devices and Ancillary Tools

Advertisement

Structural >
TAVR Devices and Ancillary Tools

Episodes

Progress in Embolic Protection 2: New Aortic Arch Deflectors Devices
Progress in Embolic Protection 2: New Aortic Arch Deflectors Devices
11 min.
Progress in Embolic Protection 1: New Debris Capture and Removal Devices
Progress in Embolic Protection 1: New Debris Capture and Removal Devices
11 min.
Update from the PROTECT H2H Trial with Emboliner (Case Example)
Update from the PROTECT H2H Trial with Emboliner (Case Example)
12 min.
Counterpoint: The Evidence Simply Doesn’t Support Cerebral Protection, and Who’s Going to Pay for it Anyway?
Counterpoint: The Evidence Simply Doesn’t Support Cerebral Protection, and Who’s Going to Pay for it Anyway?
15 min.
PROTECTED TAVR – The Case for Cerebral Embolic Protection Devices
PROTECTED TAVR – The Case for Cerebral Embolic Protection Devices
4 min.
Navitor: Early US Clinical Experience and Update From the Navitor Study
Navitor: Early US Clinical Experience and Update From the Navitor Study
9 min.
Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves
Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves
16 min.
The Next Generation of Balloon-Expandable TAVR: The SAPIEN X4 Valve and ALLIANCE Trial
The Next Generation of Balloon-Expandable TAVR: The SAPIEN X4 Valve and ALLIANCE Trial
10 min.
Navitor Case in a Box
Navitor Case in a Box
17 min.
ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies
ACURATE Neo2: Update From the ACURATE IDE and Worldwide Studies
8 min.
ACURATE Case in a Box
ACURATE Case in a Box
11 min.
Matching the Valve to the Patient: How Do I Choose With So Many THV Systems Available?
Matching the Valve to the Patient: How Do I Choose With So Many THV Systems Available?
15 min.
Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)
Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)
14 min.
TAV Designs and Compatibility
TAV Designs and Compatibility
16 min.
Leaflet Excision: The Complete Solution (Excision Medical Inc)
Leaflet Excision: The Complete Solution (Excision Medical Inc)
12 min.
DurAVR Transcatheter Heart Valve: Early Feasibility Study
DurAVR Transcatheter Heart Valve: Early Feasibility Study
10 min.
Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update
Robotically Developed Polymeric-Based Leaflet Technology (Foldax): Technology and Clinical Program Update
10 min.
Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry
Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry
12 min.
Tinkering the Ticker: TandemHeart to TAVR
Tinkering the Ticker: TandemHeart to TAVR
10 min.
High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
11 min.
Aortic Stenosis With Acute LV Unloading With Septostomy
Aortic Stenosis With Acute LV Unloading With Septostomy
13 min.
Cardiogenic Shock: ECMO Supported TAVR
Cardiogenic Shock: ECMO Supported TAVR
12 min.
Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.
Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.
13 min.
Why Evolut FX Design Matters
Why Evolut FX Design Matters
9 min.
The Clinical Impact and Importance of Efficient Hemodynamics with the SavvyWire®
The Clinical Impact and Importance of Efficient Hemodynamics with the SavvyWire®
31 min.
From Portico to Navitor
From Portico to Navitor
15 min.
Navitor Approval Study Outcomes & Best Practices
Navitor Approval Study Outcomes & Best Practices
16 min.
Perspectives of a New Navitor Implanter
Perspectives of a New Navitor Implanter
13 min.
Case Presentation - Arkansas Heart
Case Presentation - Arkansas Heart
7 min.
Case Presentation - Cleveland Clinic
Case Presentation - Cleveland Clinic
9 min.
New Edwards TAVR Technology
New Edwards TAVR Technology
12 min.
SavvyWire® to Facilitate Lifetime Patient Management and Case Efficiency with LV Pacing
SavvyWire® to Facilitate Lifetime Patient Management and Case Efficiency with LV Pacing
10 min.
Sensor-Guided Solutions for Optimizing Outcomes without Compromise
Sensor-Guided Solutions for Optimizing Outcomes without Compromise
10 min.
LVAD Associated Aortic Regurgitation: Treatment With a Dedicated TAVR System
LVAD Associated Aortic Regurgitation: Treatment With a Dedicated TAVR System
11 min.
SPOTLIGHT LECTURE: Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experience and the ALIGN AR Trial
SPOTLIGHT LECTURE: Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experience and the ALIGN AR Trial
15 min.
Surgical Updates: Surgical Aortic Valve Repair for AR
Surgical Updates: Surgical Aortic Valve Repair for AR
7 min.
Stroke after TAVR:  To Protect or Not to Protect?
Stroke after TAVR: To Protect or Not to Protect?
25 min.
Clinical Data for the ACURATE Platform
Clinical Data for the ACURATE Platform
16 min.
Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…
Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…
8 min.
Update From the Clinical Trials and Where I Would and Wouldn’t Use It
Update From the Clinical Trials and Where I Would and Wouldn’t Use It
14 min.
Pre-recorded Case: Navitor
Pre-recorded Case: Navitor
11 min.
Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx
Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx
17 min.
Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial
Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial
8 min.
Position 3: TAVR With a Supra-Annular Valve
Position 3: TAVR With a Supra-Annular Valve
6 min.
Position 2: TAVR With an Annular Valve
Position 2: TAVR With an Annular Valve
7 min.
Position 1: SAVR With Root Enlargement
Position 1: SAVR With Root Enlargement
10 min.
Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies
Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies
9 min.
Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial
Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial
9 min.
Moderate AS With ‘At Risk’ Features: The PROGRESS Trial
Moderate AS With ‘At Risk’ Features: The PROGRESS Trial
5 min.
Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure
Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure
16 min.
The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)
The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)
14 min.
An Introduction to Other New TAVR Systems (Portico Navitor, Accurate Neo 2)
An Introduction to Other New TAVR Systems (Portico Navitor, Accurate Neo 2)
11 min.
TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples
TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples
11 min.
TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples
TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples
9 min.
Excision Medical Leaflet System
Excision Medical Leaflet System
12 min.
SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments
SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments
8 min.
Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis
Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis
18 min.
Cerebral Embolic Protection in TAVR - Deflection Devices
Cerebral Embolic Protection in TAVR - Deflection Devices
7 min.
Sensor-Guided TAVR Initial experience with the SavvyWire: Post-Market Registry of the First 60 Cases
Sensor-Guided TAVR Initial experience with the SavvyWire: Post-Market Registry of the First 60 Cases
7 min.
Left Ventricle Pacing Algorithm During TAVR (Solo Pace): Program Update
Left Ventricle Pacing Algorithm During TAVR (Solo Pace): Program Update
10 min.
Cerebral Embolic Protection in TAVR - Full-Body Embolic Prottection Devices
Cerebral Embolic Protection in TAVR - Full-Body Embolic Prottection Devices
14 min.
TELLTALE: Dedicated Transcatheter Electrosurgery System
TELLTALE: Dedicated Transcatheter Electrosurgery System
6 min.
ShortCut Dedicated Aortic Leaflet Splitting Device: Clinical Experience and Emerging Indications
ShortCut Dedicated Aortic Leaflet Splitting Device: Clinical Experience and Emerging Indications
14 min.
Aortic Valve Lithotripsy Before TAVR: Early Human Clinical Experience
Aortic Valve Lithotripsy Before TAVR: Early Human Clinical Experience
6 min.
SPOTLIGHT INNOVATION LECTURE: From BASILICA to CATHEDRAL: The Growing Role of Leaflet Modification in the Structural Heart Field
SPOTLIGHT INNOVATION LECTURE: From BASILICA to CATHEDRAL: The Growing Role of Leaflet Modification in the Structural Heart Field
7 min.
Compassionate Use Experience with J-Valve for Native Aortic Regurgitation: First 30 Cases with a Dedicated Transfemoral System in North America
Compassionate Use Experience with J-Valve for Native Aortic Regurgitation: First 30 Cases with a Dedicated Transfemoral System in North America
8 min.
First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System
First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System
8 min.
Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV
Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV
8 min.
DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results
DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results
9 min.
Cerebral Embolic Protection: Why, When, and Who?
Cerebral Embolic Protection: Why, When, and Who?
7 min.
Keynote Lecture: TAVR in AR: Anatomical Considerations for Device and Technique Selection
Keynote Lecture: TAVR in AR: Anatomical Considerations for Device and Technique Selection
11 min.
JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort
JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort
7 min.
DurAVR™: Design Concept and FIH Results (Anteris)
DurAVR™: Design Concept and FIH Results (Anteris)
7 min.
A Completely Biological Engineered Tissue Valve for Transcatheter Heart Valve Applications (Vascudyne)
A Completely Biological Engineered Tissue Valve for Transcatheter Heart Valve Applications (Vascudyne)
8 min.
A Novel Polymeric Leaflet Based TAVR System (Inflow)
A Novel Polymeric Leaflet Based TAVR System (Inflow)
7 min.
ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)
ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)
8 min.
A Direct Wire Pacing Device for SHD Procedures (Electroducer Sleeve)
A Direct Wire Pacing Device for SHD Procedures (Electroducer Sleeve)
6 min.
New TAVR Platforms - PORTICO NAVITOR FLEX-NAV
New TAVR Platforms - PORTICO NAVITOR FLEX-NAV
15 min.
NEW TAVR Platforms - ACURATE NEO 2
NEW TAVR Platforms - ACURATE NEO 2
10 min.
New TAVR Platforms - EVOLUT (OPTIMIZE and SMART)
New TAVR Platforms - EVOLUT (OPTIMIZE and SMART)
6 min.
New TAVR Platforms - SAPIEN (X4 and ALLIANCE)
New TAVR Platforms - SAPIEN (X4 and ALLIANCE)
5 min.
Changing the TAVR Paradigm (Solopace)
Changing the TAVR Paradigm (Solopace)
11 min.